I need to prepare for fmge exam and want to know about all about herat and other organs detailed

Reading File
Asking for Preferences
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Here is your comprehensive FMGE heart study guide, covering all four subjects: Anatomy, Physiology, Pathology, and Pharmacology.

FMGE Heart - Complete Study Notes


PART 1: ANATOMY OF THE HEART

(Sources: Gray's Anatomy for Students; Color Atlas of Human Anatomy, Vol 2)

1.1 Position and Orientation

  • The heart has the shape of a pyramid resting on one side
  • Apex - projects forward, downward, and to the LEFT; lies in the 5th left intercostal space, 8-9 cm from midsternal line (formed by inferolateral part of left ventricle)
  • Base - faces posteriorly; quadrilateral; lies opposite vertebrae TV to TVIII (standing: TVI to TIX)
  • The esophagus lies immediately posterior to the base

1.2 Surfaces

SurfaceFormed by
Anterior (sternocostal)Mostly right ventricle + some RA (right) and LV (left)
Diaphragmatic (inferior)Left ventricle + small portion of RV
Left pulmonaryLeft ventricle (broad, convex)
Right pulmonaryRight atrium (broad, convex)
Base (posterior)Left atrium mostly + small part of RA + proximal great veins
FMGE High-Yield: The right border on CXR (PA view) = SVC + RA + IVC. The left border = arch of aorta + pulmonary trunk + left auricle + LV.

1.3 Cardiac Borders (X-Ray)

BorderStructures
Right border (PA view)SVC (upper) + RA (middle) + IVC (lower)
Left border (PA view)Aortic knuckle + Pulmonary trunk + Left auricle + LV
Inferior borderRV + LV at apex
Right anterior (lateral view)RV
Posterior (lateral view)LA

1.4 Chambers

Right Atrium:
  • Blood enters via: Superior vena cava (upper posterior), Inferior vena cava (lower posterior), Coronary sinus (lower posterior)
  • Interior divided by crista terminalis (muscular ridge) - externally marked by sulcus terminalis
  • Posterior to crista = sinus of venae cavae (smooth walls, embryologically from right horn of sinus venosus)
  • Anterior to crista = atrium proper with musculi pectinati (pectinate muscles)
  • Fossa ovalis = remnant of foramen ovale on interatrial septum; depression with a raised margin called the limbus fossae ovalis
  • Blood exits through the right atrioventricular orifice (closed by tricuspid valve)
Right Ventricle:
  • Receives blood from RA through tricuspid valve
  • Ejects blood into pulmonary trunk through pulmonary valve
  • Has trabeculae carneae (muscular ridges), papillary muscles (anterior, posterior, septal), and chordae tendineae
  • Moderator band (septomarginal trabecula) - carries right bundle branch, important in conduction
  • Wall is thinner than LV (RV:LV wall ratio ~1:3)
Left Atrium:
  • Receives 4 pulmonary veins (2 from each lung)
  • Smooth walls posteriorly; pectinate muscles only in left auricle
  • Forms most of the base of the heart
  • Ejects blood through mitral (bicuspid) valve into LV
Left Ventricle:
  • Thickest walls (~9-11 mm) - 3x thicker than RV
  • Has trabeculae carneae, papillary muscles (anterior and posterior), chordae tendineae
  • Ejects blood through aortic valve into the ascending aorta
  • Has aortic vestibule = smooth-walled outflow tract

1.5 Cardiac Valves

ValveTypeLocationCuspsKey Point
TricuspidAV valveRight AV orifice3 (anterior, posterior, septal)Right side
Mitral (bicuspid)AV valveLeft AV orifice2 (anterior, posterior)Left side
PulmonarySemilunarPulmonary trunk origin3 (anterior, left, right)No chordae
AorticSemilunarAortic orifice3 (left, right, posterior/non-coronary)Sinuses of Valsalva
FMGE High-Yield: The sinuses of Valsalva (aortic sinuses) - the left and right coronary arteries arise from the left and right aortic sinuses respectively. The posterior/non-coronary cusp has no coronary ostium.

1.6 External Sulci

  • Coronary sulcus - encircles the heart, separates atria from ventricles; contains: right coronary artery, small cardiac vein, coronary sinus, circumflex branch of LCA
  • Anterior interventricular sulcus - separates ventricles anteriorly; contains: anterior interventricular artery (LAD) + great cardiac vein
  • Posterior interventricular sulcus - separates ventricles posteriorly; contains: posterior interventricular artery (PDA) + middle cardiac vein

1.7 Coronary Circulation

Left Coronary Artery (LCA):
  • Arises from left aortic sinus
  • Divides into: LAD (Left Anterior Descending) and Circumflex artery
  • LAD supplies: anterior LV, anterior 2/3 of interventricular septum, apex, anterior papillary muscle
  • Circumflex supplies: lateral and posterior LV, posterior papillary muscle
Right Coronary Artery (RCA):
  • Arises from right aortic sinus
  • Supplies: RA, RV, SA node (55%), AV node (90%), posterior 1/3 of septum (in right-dominant circulation)
  • Gives posterior descending artery (PDA) in right-dominant pattern
FMGE High-Yield - Dominance:
  • Right-dominant (most common, ~70%) = PDA from RCA
  • Left-dominant (~15%) = PDA from circumflex
  • Co-dominant (~15%)
FMGE High-Yield - Nodal Blood Supply:
  • SA node = RCA (55%), LCA (45%)
  • AV node = RCA (90%) - the "AV nodal artery" is a branch of RCA at the crux

1.8 Cardiac Conduction System

StructureLocationFeature
SA nodeJunction of SVC and right atrium (crista terminalis)Pacemaker, 60-100 bpm
AV nodePosteroinferior part of interatrial septum (triangle of Koch)Rate 40-60 bpm; delays impulse
Bundle of HisUpper part of interventricular septumOnly conduction pathway between atria and ventricles
Right bundle branchPasses through moderator band to anterior papillary muscleReaches RV
Left bundle branchDivides into anterior and posterior fasciclesReaches LV
Purkinje fibersSubendocardial, end-organsRate 20-40 bpm; fastest conduction velocity
FMGE High-Yield: The triangle of Koch landmarks are: tendon of Todaro (posterior), tricuspid valve annulus (anterolateral), and coronary sinus ostium (inferior). The AV node sits at the apex of this triangle.

1.9 Pericardium

  • Fibrous pericardium: tough outer layer; continuous with central tendon of diaphragm; prevents acute overdistension
  • Serous pericardium: inner layer; two layers (parietal + visceral/epicardium) with pericardial cavity (15-50 mL fluid)
  • Pericardial sinuses:
    • Transverse sinus - between great arteries anteriorly and great veins posteriorly (surgically important - surgeon places finger/clamp to stop cardiac output)
    • Oblique sinus - behind left atrium between pulmonary veins
Cardiac Tamponade: Rapid fluid accumulation compresses all 4 chambers. Beck's triad: ↓BP + ↑JVP + muffled heart sounds. Kussmaul's sign = JVP rises on inspiration.

PART 2: PHYSIOLOGY OF THE HEART


2.1 Cardiac Action Potentials

Ventricular Myocyte (Fast Response):
PhaseIon movementChange
Phase 0Rapid Na+ influxRapid depolarization
Phase 1K+ efflux (Ito)Early repolarization
Phase 2Ca2+ influx = K+ effluxPlateau (unique to cardiac)
Phase 3K+ effluxRapid repolarization
Phase 4Na+/K+ ATPase restoresResting membrane potential (-85 to -90 mV)
SA/AV Node (Slow Response):
  • Phase 0 = slow Ca2+ influx (no fast Na+ channels)
  • Phase 4 = spontaneous depolarization (pacemaker potential) via If (funny current) + ICaT
  • RMP = -55 to -60 mV (less negative)
FMGE High-Yield: Cardiac muscle has an absolute refractory period that lasts almost as long as the contraction itself - this PREVENTS tetanus (unlike skeletal muscle).

2.2 Cardiac Cycle (Wiggers Diagram)

PhaseEvents
Isovolumetric contractionAll valves closed; pressure builds; begins at S1
Rapid ejectionAortic (pulmonic) valve opens; 70% stroke volume ejected
Reduced ejectionDecreasing flow
Isovolumetric relaxationAll valves closed; pressure falls; begins at S2
Rapid fillingMitral (tricuspid) valve opens; 70-75% filling
Reduced fillingPassive filling slows
Atrial systole (pre-systolic filling)Atria contract; final 25-30% filling
Heart Sounds:
  • S1 = closure of mitral + tricuspid (AV valves) at start of systole
  • S2 = closure of aortic + pulmonic (semilunar valves) at start of diastole
  • S3 = early diastole, rapid filling; normal in children, pathological in adults (HF with low EF)
  • S4 = late diastole, atrial kick against stiff ventricle; always pathological (LVH, hypertensive heart disease)

2.3 Frank-Starling Law

  • Increased preload (venous return, end-diastolic volume) → increased stretch of myocardial fibers → increased force of contraction → increased stroke volume
  • Within physiological limits: greater EDV = greater SV
  • Mechanism: optimal actin-myosin overlap at sarcomere length of ~2.2 μm
Key definitions:
  • Preload = end-diastolic volume (EDV); approximated by end-diastolic pressure
  • Afterload = resistance to ejection; approximated by aortic pressure / systemic vascular resistance
  • Contractility (inotropy) = intrinsic ability of heart to contract independent of preload/afterload
  • Cardiac Output = Heart Rate × Stroke Volume (normal = 5 L/min)
  • Ejection Fraction (EF) = SV/EDV × 100%; normal = 55-70%

2.4 Regulation of Heart Rate

StimulusEffectReceptor
Sympathetic (NE)↑HR, ↑contractility, ↑conduction velocityβ1 receptors
Parasympathetic (ACh)↓HR, ↓AV conductionM2 receptors
↑Body temperature↑HRDirect on SA node
HypoxiaInitially ↑HR, then ↓Reflex + direct
Starling's reflex↑HR with ↑venous returnAtrial stretch receptors

2.5 Pressure Values (FMGE-Memorize)

Chamber/VesselSystolicDiastolic
Right atrium0-8 mmHg(mean)
Right ventricle15-250-8
Pulmonary artery15-258-15
Pulmonary capillary wedge pressure~8-12 mmHg (mean)
Left atrium5-12 mmHg(mean)
Left ventricle100-1403-12
Aorta100-14060-90

PART 3: PATHOLOGY OF THE HEART

(Source: Robbins & Kumar Basic Pathology; Goldman-Cecil Medicine)

3.1 Ischemic Heart Disease (IHD)

Risk Factors: Hypertension, hyperlipidemia, smoking, diabetes, family history, obesity, male sex, age.
Pathogenesis: Atherosclerosis → plaque rupture → thrombosis → coronary occlusion → ischemia/infarction.
Spectrum of IHD:
  1. Stable angina - Fixed plaque, >70% stenosis; pain on exertion, relieved by rest
  2. Unstable angina - Plaque rupture + non-occlusive thrombus; ACS without troponin rise
  3. NSTEMI - Partial coronary occlusion; subendocardial infarction; troponin positive; no ST elevation
  4. STEMI - Complete occlusion; transmural infarction; ST elevation; requires urgent reperfusion
Zones of infarction:
  • Zone of necrosis (center)
  • Zone of injury (ST elevation on ECG)
  • Zone of ischemia (T-wave changes)
Timeline of MI changes (Robbins):
TimeGrossMicroscopic
0-4 hoursNone visibleWavy fibers, edema
4-12 hoursDark mottlingCoagulative necrosis begins, contraction bands
12-24 hoursPallorNeutrophilic infiltration
1-3 daysPale with yellow centerNeutrophils, nuclear pyknosis
3-7 daysYellow-tan, softenedMacrophage infiltration begins
1-2 weeksYellow-tan with red bordersGranulation tissue, fibroblasts
2-8 weeksWhite scar formingDense collagen (fibrosis)
>2 monthsWhite scarComplete fibrosis
Cardiac Biomarkers:
  • Troponin I / Troponin T - most specific and sensitive; rises at 3-4 hours, peaks at 24-48 hours, returns to baseline in 7-10 days (high-sensitivity troponin detects at 1-2 hours)
  • CK-MB - rises at 4-6 hours, peaks 24 hours, normal at 48-72 hours; useful for re-infarction
  • Myoglobin - earliest (1-2 hours), not specific
Complications of MI:
  • Arrhythmias - most common cause of death in first 24 hours
  • Cardiogenic shock - loss of >40% LV mass
  • Papillary muscle rupture - acute MR (2-7 days)
  • Free wall rupture - hemopericardium/tamponade (3-7 days)
  • Ventricular septal rupture - new harsh systolic murmur (3-7 days)
  • LV aneurysm - late complication; persistent ST elevation
  • Pericarditis - Dressler syndrome = weeks to months later (autoimmune)
  • Mural thrombus → emboli

3.2 Heart Failure

Classification by EF (Goldman-Cecil Medicine):
TypeEFFeatures
HFrEF (Heart Failure with reduced EF)≤40%Systolic dysfunction; dilated LV
HFmrEF (mildly reduced EF)41-49%"Gray zone"
HFpEF (Heart Failure with preserved EF)≥50%Diastolic dysfunction; stiff LV
Staging (ACC/AHA):
  • Stage A - Risk factors only; no structural disease; no symptoms
  • Stage B - Structural disease (e.g., post-MI, LVH) but no symptoms
  • Stage C - Structural disease + current/past symptoms
  • Stage D - Refractory HF requiring advanced therapies
NYHA Functional Classification:
  • Class I: No symptoms
  • Class II: Symptoms with moderate activity
  • Class III: Symptoms with minimal activity
  • Class IV: Symptoms at rest
Left HF vs Right HF:
FeatureLeft HFRight HF
CauseIHD, HTN, aortic/mitral diseaseLeft HF, pulmonary HTN, RV infarct
SymptomsDyspnea, orthopnea, PND, pink frothy sputumAnkle edema, ascites, RUQ pain
SignsPulmonary crackles, S3JVP raised, hepatomegaly, pitting edema

3.3 Valvular Heart Disease (FMGE High-Yield)

Aortic Stenosis (AS):
  • Most common: calcific/degenerative (elderly) or bicuspid aortic valve (young)
  • Murmur: Harsh systolic ejection murmur; radiates to carotids; heard best in aortic area (2nd right ICS)
  • Symptoms (SAD triad): Syncope + Angina + Dyspnea
  • Signs: slow rising, plateau pulse (pulsus parvus et tardus); narrow pulse pressure; LV heave; absent A2
  • FMGE Key: Severe AS = valve area <1 cm², gradient >40 mmHg
Aortic Regurgitation (AR):
  • Causes: Rheumatic, infective endocarditis, Marfan syndrome, aortic dissection, syphilitic aortitis
  • Murmur: Early diastolic (blowing, decrescendo); heard at left sternal border; Austin Flint murmur (mid-diastolic, apex)
  • Pulse: Collapsing/water-hammer pulse; wide pulse pressure
  • Signs: Corrigan sign, de Musset sign, Traube sign (pistol shot femoral), Quincke sign (nail pulsations)
Mitral Stenosis (MS):
  • Almost always rheumatic in origin
  • Murmur: Mid-diastolic with presystolic accentuation; heard best at apex in left lateral position; low-pitched
  • Opening snap follows S2 closely in severe MS
  • Signs: Malar flush, atrial fibrillation, loud S1, mitral facies
  • Complications: AF, pulmonary HTN, right HF, infective endocarditis, systemic emboli
  • FMGE Key: Normal valve area = 4-6 cm²; Mild MS >1.5 cm²; Severe MS <1 cm²
Mitral Regurgitation (MR):
  • Causes: Rheumatic, MVP, IHD (papillary muscle dysfunction), infective endocarditis
  • Murmur: Pansystolic (holosystolic) murmur; at apex; radiates to axilla
  • Signs: Displaced, thrusting apex beat; S3 gallop; signs of pulmonary edema
Mitral Valve Prolapse (MVP):
  • Most common valvular disease in Western countries
  • Mid-systolic click + late systolic murmur
  • Associated with Marfan syndrome

3.4 Congenital Heart Disease

Acyanotic (L→R shunts - initially):
DefectFeaturesMurmur
ASDSecundum most common; fixed split S2; pulmonary plethoraEjection systolic in pulmonary area
VSDMost common CHD overall; membranous type most commonHarsh pansystolic, lower left sternal border
PDAFailure of ductus arteriosus to close; bounding pulses; wide pulse pressureContinuous "machinery" murmur (Gibson murmur) at 2nd left ICS
Cyanotic (R→L shunts):
DefectFeaturesFMGE Key
Tetralogy of Fallot (ToF)VSD + pulmonary stenosis + overriding aorta + RVHMost common cyanotic CHD; Boot-shaped heart on CXR; squatting relieves cyanosis
Transposition of Great Arteries (TGA)Aorta from RV, pulmonary artery from LVEgg-on-string/side CXR; incompatible with life without mixing; PDA/ASD/VSD needed
Tricuspid AtresiaAbsent tricuspid; requires ASD + VSD
Total Anomalous Pulmonary Venous Return (TAPVR)All pulmonary veins drain into systemic venous systemSnowman (figure-of-8) CXR
Eisenmenger Syndrome: Reversal of L→R shunt to R→L due to pulmonary hypertension. Cyanosis develops late. Once established, contraindicated for surgical repair.

3.5 Cardiomyopathies

TypePathologyFMGE Key
Dilated (DCM)LV/biventricular dilation, systolic dysfunctionMost common (idiopathic, alcohol, viral, post-partum); S3 gallop
Hypertrophic (HCM)LV/septal hypertrophy; diastolic dysfunction; outflow obstructionAD inheritance; mutations in sarcomere proteins (MYH7, MYBPC3); sudden cardiac death in young athletes
Restrictive (RCM)Stiff ventricle; filling impaired; systolic usually preservedAmyloidosis, sarcoidosis, hemochromatosis; normal/small heart
HCM - FMGE High-Yield:
  • Outflow obstruction worsened by: vasodilators, dehydration, standing, Valsalva
  • Obstruction relieved by: squatting, leg raising, beta-blockers
  • Murmur: systolic ejection; increases with Valsalva

3.6 Pericardial Disease

Acute Pericarditis:
  • Causes: Viral (most common - Coxsackie B), autoimmune, TB, uremia, post-MI
  • Classic symptom: Sharp pleuritic chest pain relieved by sitting forward
  • ECG: Diffuse concave-up (saddle-shaped) ST elevation in all leads except aVR and V1; PR depression
  • Treatment: NSAIDs + colchicine
Cardiac Tamponade:
  • Rapid accumulation of pericardial fluid compresses chambers
  • Beck's Triad: Hypotension + Elevated JVP + Muffled heart sounds
  • Kussmaul's sign: JVP rises on inspiration (paradoxical - also in constrictive pericarditis)
  • Pulsus paradoxus: SBP falls >10 mmHg on inspiration
  • Treatment: Pericardiocentesis
Constrictive Pericarditis:
  • Causes: TB (especially in developing countries), post-viral, post-radiation
  • Kussmaul's sign (positive); pericardial knock (S3-like sound); calcified pericardium on CXR/CT
  • Equalization of all diastolic pressures

PART 4: PHARMACOLOGY OF THE HEART

(Source: Goldman-Cecil Medicine; Braunwald's Heart Disease)

4.1 Heart Failure Pharmacology

Drugs Used by Stage (Goldman-Cecil):
Drug ClassStage AStage BStage C (HFrEF)Stage D
ACE Inhibitors / ARBs
Beta-blockers-
SGLT2 inhibitors-
ARNI (Sacubitril-Valsartan)--
Mineralocorticoid antagonists (Spironolactone)--
Ivabradine--
Digoxin--
Hydralazine + Nitrates--
ICD-(✓)
CRT--
LVAD---
FMGE Key Facts:
  • ARNI (Sacubitril/Valsartan) = neprilysin inhibitor + ARB; preferred over ACEi in Stage C HFrEF
  • Carvedilol, Metoprolol succinate, Bisoprolol = beta-blockers with proven mortality benefit in HF
  • Spironolactone/Eplerenone = aldosterone antagonists; reduce mortality in HFrEF
  • SGLT2i (Dapagliflozin, Empagliflozin) = new evidence for mortality benefit regardless of diabetes status
  • Ivabradine = If channel blocker; reduces HR without affecting contractility; use if HR >70 despite beta-blocker

4.2 Antihypertensives (Mechanism and Choice)

Drug ClassMechanismKey Use/Notes
ACE Inhibitors (-pril)Block ACE → ↓Angiotensin II → ↓aldosterone, ↓vasoconstriction1st line in DM nephropathy, HF, post-MI; SE: dry cough, angioedema
ARBs (-sartan)Block AT1 receptorUse when ACEi not tolerated (no cough)
Beta-blockersBlock β1 (HR, contractility), β2 (bronchoconstriction)Contraindicated in asthma; 1st line in angina, post-MI, HF
Calcium channel blockers (CCBs)Block L-type Ca2+ channelsDihydropyridines (amlodipine) = vasodilation; Non-DHP (verapamil, diltiazem) = ↓HR + vasodilation
Thiazide diureticsInhibit NaCl cotransporter in DCT1st line in isolated systolic HTN in elderly; hypokalemia risk
Loop diuretics (furosemide)Inhibit Na-K-2Cl in loop of HenleAcute pulmonary edema, HF; most potent diuretics
Aldosterone antagonistsBlock mineralocorticoid receptorSpironolactone: HF, hyperaldosteronism; Eplerenone: fewer anti-androgen SEs
HydralazineDirect arteriolar vasodilatorHF in those who cannot tolerate ACEi/ARB; pregnancy-induced HTN
NitratesRelease NO → ↑cGMP → venodilationAngina; headache SE; tolerance develops

4.3 Antiarrhythmic Drugs (Vaughan Williams Classification)

ClassMechanismExamplesUsed For
IaNa+ channel block (moderate); ↑AP durationQuinidine, Procainamide, DisopyramideAF, VT
IbNa+ channel block (fast); ↓AP durationLidocaine, MexiletineVT, VF (post-MI)
IcNa+ channel block (strong); no AP duration changeFlecainide, PropafenoneSVT, AF (no structural disease)
IIBeta-blockersMetoprolol, Atenolol, EsmololAF rate control, SVT, post-MI
IIIK+ channel block; ↑AP duration, ↑refractory periodAmiodarone, Sotalol, IbutilideAF, VT, VF
IVCCB (non-DHP)Verapamil, DiltiazemSVT, AF rate control
UnclassifiedAdenosineAdenosineDrug of choice for acute SVT; causes transient AV block
UnclassifiedDigoxinDigoxinAF rate control; HFrEF
Amiodarone (FMGE High-Yield):
  • Broad-spectrum antiarrhythmic (Class I, II, III, IV properties)
  • Most effective antiarrhythmic overall but high toxicity
  • Side effects: Pulmonary fibrosis, thyroid dysfunction (hyper/hypo), corneal microdeposits, bluish skin discoloration, hepatotoxicity, peripheral neuropathy
  • Prolongs QT interval → risk of Torsades de Pointes
Digoxin:
  • Mechanism: Inhibits Na+/K+ ATPase → ↑intracellular Ca2+ → positive inotrope
  • Vagomimetic effect on AV node → ↓HR
  • Narrow therapeutic index (0.5-2 ng/mL)
  • Toxicity: N/V, visual disturbances (xanthopsia = yellow vision), arrhythmias
  • Toxicity worsened by: hypokalemia, hypomagnesemia, renal failure

4.4 Drugs in Acute MI

DrugRole
AspirinImmediate (160-325 mg chewed); irreversible COX-1 inhibition
P2Y12 inhibitors (Clopidogrel, Ticagrelor)Dual antiplatelet with aspirin; Ticagrelor preferred in STEMI
Heparin/LMWHAnticoagulation during PCI or thrombolysis
Beta-blockersReduce O2 demand; prevent arrhythmias; improve survival
NitratesRelieve chest pain; vasodilation
Thrombolytics (Streptokinase, tPA)If PCI not available within 2 hours; use in STEMI <12 hours
ACE InhibitorsWithin 24 hours in STEMI with LV dysfunction; prevent remodeling
StatinsHigh-intensity (Atorvastatin 80 mg) - plaque stabilization
MorphinePain relief; also mild venodilation

4.5 Drugs in Angina

Drug ClassEffectNotes
Short-acting nitratesVenodilation (↓preload) + coronary vasodilationSublingual GTN for acute attacks
Long-acting nitratesProphylaxisNitrate tolerance - drug-free interval needed
Beta-blockers↓HR, ↓contractility → ↓O2 demandFirst-line in chronic stable angina
CCBs (non-DHP)↓HR + vasodilationVariant (Prinzmetal) angina = CCBs preferred
RanolazineInhibits late Na+ currentAdd-on; no effect on HR or BP
Ivabradine↓HR (If channel)When beta-blockers contraindicated

FMGE HIGH-YIELD QUICK RECALL

Murmur Summary

MurmurTimingSiteRadiation
Aortic StenosisSystolic ejection2nd R ICSCarotids
Aortic RegurgitationEarly diastolicLeft sternal border-
Mitral StenosisMid-diastolicApex-
Mitral RegurgitationPansystolicApexAxilla
MVPMid-systolic click + late systolicApex-
VSDPansystolicLeft lower sternal border-
PDAContinuous machinery2nd left ICS-
ASDEjection systolic2nd left ICS-

Congenital Heart Disease CXR

ConditionCXR Finding
ToFBoot-shaped heart (coeur en sabot)
TGAEgg-on-string / Egg-on-side
TAPVRSnowman sign (figure-of-8)
MSDouble right heart border; left atrial enlargement
ASDPulmonary plethora; RV enlargement
PDAEnlarged LA + LV; pulmonary plethora

Key Numbers to Memorize

  • Normal EF: 55-70%
  • HFrEF: EF ≤40%
  • Normal mitral valve area: 4-6 cm²
  • Severe MS: <1 cm²
  • Severe AS: valve area <1 cm², gradient >40 mmHg
  • Apex beat: 5th left ICS, 8-9 cm from midsternal line
  • SA node innervation: RCA 55%, LCA 45%
  • AV node innervation: RCA 90%

Sources: Gray's Anatomy for Students (Gray's); Goldman-Cecil Medicine; Braunwald's Heart Disease (Braunwald); Fuster and Hurst's The Heart, 15th Ed; Robbins & Kumar Basic Pathology

This covers the core heart content tested in FMGE across all four subjects. If you want me to go deeper on any specific topic (e.g., ECG interpretation, congenital heart disease pathophysiology, specific drug mechanisms, arrhythmia management), just ask and I'll pull the relevant textbook sections.
This is a shared conversation. Sign in to Orris to start your own chat.